Overview
Paul Berard is a Hematologist Oncology specialist and a Hematologist in Fairfield, Connecticut. Dr. Berard is rated as an Experienced provider by MediFind in the treatment of Inflammatory Breast Cancer. His top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Pleuropulmonary Blastoma, and Lung Cancer.
His clinical research consists of co-authoring 1 peer reviewed article and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
425 Post Rd, Suite 204, Fairfield, CT 06824
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Weill Medical College Of Cornell
Massimo Cristofanilli is a Hematologist Oncology specialist and an Oncologist in New York, New York. Dr. Cristofanilli is rated as a Distinguished provider by MediFind in the treatment of Inflammatory Breast Cancer. His top areas of expertise are Inflammatory Breast Cancer, Breast Cancer, Triple-Negative Breast Cancer, Paget Disease of the Breast, and Tissue Biopsy.
Yale University
Lajos Pusztai is an Oncologist in New Haven, Connecticut. Dr. Pusztai is rated as a Distinguished provider by MediFind in the treatment of Inflammatory Breast Cancer. His top areas of expertise are Triple-Negative Breast Cancer, Breast Cancer, Inflammatory Breast Cancer, HER2 Negative Breast Cancer, and Tissue Biopsy.
Yale University
Eric Winer is an Oncologist and a Hematologist Oncology provider in New Haven, Connecticut. Dr. Winer is rated as an Elite provider by MediFind in the treatment of Inflammatory Breast Cancer. His top areas of expertise are Breast Cancer, Triple-Negative Breast Cancer, HER-2 Positive Breast Cancer, and Breast Cancer in Men.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Colorectal CancerDr. Berard isDistinguished. Learn about Colorectal Cancer.
- Familial Colorectal CancerDr. Berard isDistinguished. Learn about Familial Colorectal Cancer.
- Advanced
- Adult Immune ThrombocytopeniaDr. Berard isAdvanced. Learn about Adult Immune Thrombocytopenia.
- AgranulocytosisDr. Berard isAdvanced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung Cancer
- AnemiaDr. Berard isAdvanced. Learn about Anemia.
- Childhood Iron Deficiency AnemiaDr. Berard isAdvanced. Learn about Childhood Iron Deficiency Anemia.
- Cholangiocarcinoma (Bile Duct Cancer)
- Experienced
- Acute Arterial Occlusion of KidneyDr. Berard isExperienced. Learn about Acute Arterial Occlusion of Kidney.
- Acute Mountain SicknessDr. Berard isExperienced. Learn about Acute Mountain Sickness.
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Berard isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Adult Soft Tissue SarcomaDr. Berard isExperienced. Learn about Adult Soft Tissue Sarcoma.